openPR Logo
Press release

Pain Management Therapeutics Market US Analysis and Forecasts To 2022

08-09-2017 03:04 PM CET | Health & Medicine

Press release from: MarketReportsOnline

Pain Management Therapeutics Market US Analysis and Forecasts

The United States market for pain management therapeutics market remains a substantial growth area for pharmaceutical companies, as they continue their efforts to maintain significant growth margins by tapping into markets of major unmet medical needs.

Complete report available at http://www.marketreportsonline.com/647095.html.

United States Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing pain related health ailment issue. The widespread availability of drugs and the advent of new drugs have accelerated the pace of growth in the market.

The pain management market is fueled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post-operative pain relief markets. The largest segment of the United States pain management market is the arthritis while pediatric pain is the smallest segment for the pain management. The cancer pain management market is the most rapidly growing segment of the United States pain management market.

Order a copy of this “United States Pain Management Therapeutics Market” research report at http://www.marketreportsonline.com/contacts/purchase.php?name=647095.

Company Wise Pipeline Analysis (By Product, Indication, Phase of Development) – 50 Companies Covered: Teva Pharmaceutical, Astellas Pharmaceuticals Inc., Durect Corporation, Pfizer, AbbVie Inc., AcelRx Pharmaceuticals, Inc., Acorda Therapeutics Inc., Achelios Therapeutics, Alder BioPharmaceuticals Inc., Allergan, Amgen Inc., AstraZeneca/MedImmune, Avanir Pharmaceuticals Inc., Axsome Therapeutics, Inc, BioDelivery Sciences International, Cara Therapeutics, COLLEGIUM Pharmaceutical Inc., Centrexion Therapeutics, Daiichi Sankyo Company Ltd., Depomed Inc., Egalet Corporation, Eli Lilly and Company, Endo Pharmaceuticals Inc., EpiCept, FemmePharma, Flexion Therapeutics Inc., Galapagos NV, Heron Therapeutics, Helsinn Healthcare SA, INSYS THERAPEUTICS, INC, Iroko Pharmaceuticals, KemPharm, Inc, Mesoblast Ltd, Novartis International AG, Nuvo Pharmaceuticals, Nektar Therapeutics, NeurAxon, Newron Pharmaceuticals, Olatec Industries, Otsuka Pharmaceutical, PLx Pharma, Orexo AB, Regeneron Pharmaceuticals Inc., Recro Pharma, Inc, Relmada Therapeutics, Inc, Scintilla Pharmaceuticals, Inc., Trevena Inc., Trigemina, Inc., WEX Phamaceuticals Inc, Zynerba Pharmaceuticals, Inc.

“United States Pain Management Therapeutics Market, Patients Volume, and 50 Company’s Pipeline Analysis (By Product, Indication, Phase of Development)” provides a comprehensive assessment of the fast-evolving, high-growth of United States Pain Management Therapeutics Sector.

This 77 Page report with 45 Figures and 3 Tables studies in details:
United States Pain Management Therapeutics Market and Forecast (2007 - 2022)
United States Pain Management Patients Volume and Forecast (2007 - 2022)
50 Company’s Pipeline Product Analysis (By Product, Indication, Phase of Development)
United States Pain Management Therapeutics Market - Driving Factors & Challenges

10 Pain Management Segments covered in the report are as follows
1. Arthritis Pain
2. Migraine Pain
3. Post-Operative Pain
4. Cancer Pain
5. Neuropathic Pain
6. Back Pain
7. Fibromyalgia Pain
8. Facial Pain
9. Pediatric Pain
10. Obstetrical Pain

Major points from Table of Contents Provided in US Pain Management Therapeutics Market:

1. Executive Summary

2. United States - Pain Management Therapeutics Market

3. United States - Pain Management Patient Population

4. United States - Pain Management Therapeutics Market Share

5. United States - Segment Wise Pain Management Therapeutics Market & Population
5.1 United States - Arthritis Pain Management Therapeutics Analysis (2007 - 2022)
5.1.1 United States - Arthritis Pain Management Therapeutics Market & Forecast
5.1.2 United States - Arthritis Pain Management Therapeutics Population & Forecast
5.2 United States - Migraine Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.2.1 United States - Migraine Pain Management Therapeutics Market & Forecast
5.2.2 United States - Migraine Pain Management Patient Population & Forecast
5.3 United States - Post Operative Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.3.1 United States - Post Operative Pain Management Therapeutics Market & Forecast
5.3.2 United States - Post Operative Pain Management Patient Population & Forecast
5.4 United States - Cancer Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.4.1 United States - Cancer Pain Management Therapeutics Market & Forecast
5.4.2 United States - Cancer Pain Management Patient Population & Forecast
5.5 United States - Neuropathic Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.5.1 United States - Neuropathic Pain Management Therapeutics Market & Forecast
5.5.2 United States - Neuropathic Pain Management Patient Population & Forecast
5.6 United States - Back Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.6.1 United States - Back Pain Management Therapeutics Market & Forecast
5.6.2 United States - Back Pain Management Patient Population & Forecast
5.7 United States - Fibromyalgia Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.7.1 United States - Fibromyalgia Pain Management Therapeutics Market & Forecast
5.7.2 United States - Fibromyalgia Pain Management Patient Population & Forecast
5.8 United States - Facial Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.8.1 United States - Facial Pain Management Therapeutics Market & Forecast
5.8.2 United States - Facial Pain Management Patient Population & Forecast
5.9 United States - Pediatric Pain Management Therapeutics Market, Population & Forecast (2007 - 2022)
5.9.1 United States - Pediatric Pain Management Therapeutics Market & Forecast
5.9.2 United States - Pediatric Pain Management Patient Population & Forecast
5.10 United States - Obstetrical Pain Management Therapeutics Market, Population & Forecast (2005 - 2018)
5.10.1 United States - Obstetrical Pain Management Therapeutics Market & Forecast

6. Pain Management Therapeutics Pipeline Products - By Company, Indication, Phase of Development

7. United States Pain Management Therapeutics Market - Driving Factors
7.1 Elderly Population
7.2 Unmet Need but Strong Pipeline Products

Explore more related reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Therapeutics Market US Analysis and Forecasts To 2022 here

News-ID: 662473 • Views:

More Releases from MarketReportsOnline

US Lettuce & Chicory Market Key Players, Exports & Imports, Size, Share, Demands …
The US lettuce and chicory market is forecasted to reach US$5.09 billion in 2026, experiencing growth at a CAGR of 2.62% during the period spanning from 2022 to 2026. Growth in the lettuce and chicory market is supported by factors such as rising population, rising middle class spending, shift towards veganism/ vegetarianism, increasing awareness regarding the health benefit of chicory and rising social media influence. However, the market growth is
Global Breast Biopsy Market - Hologic, Danaher Corporation, Becton, Dickinson & …
The global breast biopsy market is forecasted to reach US$1.75 billion in 2025, experiencing growth at a CAGR of 8.56% for the period spanning 2022-202. Growth in the global breast biopsy market was supported by factors such as increasing prevalence of breast cancer and rising female population aged 65 or above. Growing adoption of liquid biopsy is likely to have a positive impact on the global breast biopsy market. However,
Global Contract Development & Manufacturing Organization Market - Catalent, Inc. …
The global Contract Development & Manufacturing Organization (CDMO) market is estimated to reach US$246.6 billion in 2026, growing at a CAGR of 9.31%, for the period spanning 2022-2026. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand for pharmaceutical products are expected to drive the market.
Korean Gaming Market (Mobile, PC and Console) - Netmarble, Pearl Abyss, NCSoft, …
The Korean gaming market is anticipated to reach US$20.98 billion in 2026, growing at a CAGR of 6.21% during the period spanning 2022-2026. After the U.S., China, and Japan, it is the fourth largest market, accounting for more than 6% of the worldwide gaming industry in 2021. The growth in the market has been driven by factors like rising smartphone penetration, rapid urbanization, rising gaming subscribers' penetration rate, expansion of MMORPGs,

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and